Clinical Trial Detail

NCT ID NCT03833661
Title M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

biliary tract cancer

Therapies

M7824

Age Groups: senior adult

No variant requirements are available.